Anzeige
Mehr »
Freitag, 06.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Pharmaceutical Technology

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
MoSanofi and Regeneron report results from two Phase III trials of COPD treatment
MoASCO25: MSD's KRAS G12C drug shows early promise in Phase I
MoASCO25: Regeneron unpacks positive Libtayo data in adjuvant CSCC as Keytruda stumbles
MoCirCode Biomed gains clearance from FDA for RNA drug HM2002
MoZymeworks' zanidatamab gains approval in China for biliary tract cancer
30.05.ASCO25: Pfizer's Braftovi combo boasts 47% drop in disease progression in mCRC
30.05.EyePoint advances with Duravyu Phase III trial
30.05.Alvotech and Advanz to commercialise biosimilars in Europe
30.05.FDA rejects Stealth Bio's Barth syndrome treatment after 16.5-month review
30.05.Astellas and Evopoint sign ADC licensing deal
30.05.Daiichi Sankyo and MSD withdraw US application for lung cancer BLA
29.05.Solid tumours: CAR-T therapies' Waterloo
29.05.Regeneron to deploy Telesis Bio's Gibson SOLA at R&D facilities
29.05.iTeos to shut down following $2bn GSK-partnered TIGIT asset failure
29.05.FDA approves Eton's application for hydrocortisone oral solution
29.05.EC approves BMS' nivolumab SC formulation for solid tumours
28.05.FDA grants RMAT designation to AbelZeta's CAR-T therapy
28.05.4x the Performance, Zero Compromise: How Functionalized Polymers Are Changing the Rules
28.05.How 3PL providers are gearing up for the wave of cell and gene therapies
28.05.CDC drops Covid-19 vaccine for healthy children and pregnant women
28.05.GlycoEra secures $130m to progress IgG4-targeted protein degrader
28.05.Biogen and City Therapeutics to develop RNAi therapy
27.05.How the cell and gene therapy market is taking shape
27.05.Eli Lilly to expand pain pipeline with $1bn SiteOne buyout
27.05.Capitalising on UK's goal to become a world-leading clinical trial destination